Tivic Health Systems's EPS (Basic) for the
three
months ended in Dec. 2023 was $-1.53.
Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2023 was $-21.01.
During the past 3 years, the average EPS without NRIGrowth Rate was 35.60% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.
During the past 5 years, Tivic Health Systems's highest 3-Year average EPS without NRI Growth Rate was 35.60% per year. The lowest was -33.40% per year. And the median was 1.10% per year.
Tivic Health Systems EPS (Diluted) Historical Data
The historical data trend for Tivic Health Systems's EPS (Diluted) can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Tivic Health Systems's EPS (Diluted)
For the Medical Devices subindustry, Tivic Health Systems's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Tivic Health Systems's PE Ratio Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Tivic Health Systems's PE Ratio distribution charts can be found below:
* The bar in red indicates where Tivic Health Systems's PE Ratio falls into.
Tivic Health Systems EPS (Diluted) Calculation
EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.
Tivic Health Systems's Diluted EPS for the fiscal year that ended in Dec. 2023 is calculated as
EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-21.01
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Tivic Health Systems (NAS:TIVC) EPS (Diluted) Explanation
EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.
Be Aware
Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.
If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.
Tivic Health Systems EPS (Diluted) Related Terms
Thank you for viewing the detailed overview of Tivic Health Systems's EPS (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.
Tivic Health Systems (Tivic Health Systems) Business Description
Tivic Health Systems Inc is a health technology company focused on developing and commercializing non-invasive bioelectronic medicine. The company's platform-based technology activates the body's own healing mechanisms and can be programmed to treat various disease conditions. company's products provide a natural alternative to the standard synthetic chemical methods used by the pharmaceutical industry. ClearUP Sinus Relief, is a first commercial product of the company which is a patented handled device that uses ultra-low current electrical waves to relieve sinus pain and congestion symptoms that are prevalent in nasal allergies, sinus infections, chronic sinusitis, cold and flu and other disease conditions.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
TIVC has been successfully added to your 